Tag: Lung cancer
Mersana’s XMT-1536 Demonstrates Anti-tumor Activity in Lung Cancer Patient-Derived Xenograft Studies
Encouraging data from preclinical studies presented at the 2016 IASLC 17th World Conference on Lung Cancer, in Vienna, Austria, suggests that Mersana Therapeutics' immunoconjugate XMT-1536...
Novel Targeted Treatment for Small Cell Lung Cancer Shows Promise
Small cell lung cancer or SCLC is an aggressive disease that is difficult to treat and is frequently only diagnosed when it has metastasized...
Sacituzumab govitecan (IMMU-132) Shows Positive Interim Phase II Results
Sacituzumab govitecan also known as IMMU-132, an antibody-drug conjugate being developed by Immunomedics, a clinical-stage biopharmaceutical company, continues to produce durable responses in patients with...
A New Dawn
It's a new dawn. It's a new day.
These powerful words in one of my favorite songs ("Feeling Good") by American Singer Nina Simone, remind...
Novel Targeted Lung Cancer Therapies are Expected to Replace Current Conventional...
Lung cancer, which is mostly a disease of the elderly*, is defined as the uncontrolled growth of abnormal cells in one or both lungs. Approximately 60%...
